Business
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, flu vaccination demand is surging, projected to climb from USD 8.96 billion in 2024 to USD 13.32 billion by 2030, at a CAGR of 7%. Rising geriatric populations, government support, and public health campaigns fuel this expansion. Dominant market segments include quadrivalent vaccines, inactivated typ
About this update from Gsk Plc
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, flu vaccination demand is surging, projected to climb from USD 8.96 billion in 2024 to USD 13.32 billion by 2030, at a CAGR of 7%. Rising geriatric populations, government support, and public health campaigns fuel this expansion. Dominant market segments include quadrivalent vaccines, inactivated types, egg-based technologies, and adult-specific formulations. North America leads, while Asia Pacific is set for rapid growth. The sector faces challenges like extended production times but benefits from trends in AI and technology. Key players like GlaxoSmithKline and Moderna are innovating to capture market opportunities.","length":828,"tagName":"p"},{"type":"text","content":"Dublin, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The "Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030" report has been added to ResearchAndMarkets.com's offering.","length":301,"tagName":"p"},{"type":"text","content":"The global influenza vaccine market in 2024 stood at US8.96 billion, and is likely to reach US$13.32 billion by 2030. The market is expected to grow at a CAGR of approx. 7% during the forecasted period of 2025-2030.The key players are constantly investing in strategic initiatives, such as adoption of new technologies, introducing their services to emerging markets and more, to maintain a competitive edge in this market. For instance, in June 2024, Sinovac announced a U$100 million investment in Brazil to establish local production of vaccines and monoclonal antibodies, and to advance cell therapy initiatives....